Tirzepatide has emerged as a groundbreaking treatment for type 2 diabetes, offering promising effects. However, the price of this innovative drug and its availability have become key concerns for patients and healthcare providers. While tirzepatide has been approved by regulatory agencies, its expensive nature presents a significant obstacle to ma